Min Woo Park, Ph.D., advises clients on a broad range of patent law matters, including litigation, Section 337 investigations before the U.S. International Trade Commission (ITC), post-grant proceedings, pre-suit diligence, patent prosecution and licensing.
Min draws on extensive legal and technical experience to help clients protect and enforce intellectual property involving sophisticated technologies. He has handled patent matters involving pharmaceuticals, medical devices, telecommunications, mobile devices, optical communications, chemicals, mechanical devices, automotive technologies, semiconductors, and image compression and streaming technologies.
View More
Before joining Pillsbury, Min began his legal career at a Tokyo-based law firm, where he focused on patent prosecution before the Japan Patent Office. He subsequently joined a boutique intellectual property firm in Washington, D.C., where his practice shifted to patent litigation, with a particular emphasis on Section 337 investigations. More recently, Min practiced at a large global law firm, handling a diverse mix of patent prosecution, opinion work, post grant proceedings and litigation.
Before entering the legal profession, Min conducted doctoral research in the life sciences, including DNA and protein sequencing and editing, protein purification, enzyme assays, transgenic animal analysis, and mammalian and human cell culture.
Representative Experience
- Represented a Korean pharmaceutical company in an ITC investigation involving claims of trade secret misappropriations and conversion, resulting in a finding of no violation in favor of the client.
- Represented a Korean lithium rechargeable battery manufacturer against a competitor in an ITC investigation involving claims of patent infringement, leading to a finding of infringement by the competitor and a successful settlement.
- Represented a Japanese manufacturer of submarine internet network components against a competitor in an ITC investigation involving claims of patent infringement, leading to a summary determination that terminated the investigation for one patent and findings of noninfringement, invalidity and lack of domestic industry for the remaining asserted patents.
View More
- Represented an eyewear manufacturer in multiple Inter-Partes Reviews, successfully invalidating all challenged claims.
- Advised a Japanese pharmaceutical company in a Hatch-Waxman litigation involving a drug for treating schizophrenia and bipolar depression, leading to a successful settlement for the client.
- Represented a California-based medical/beauty device company against competitors in an ITC investigation, leading to a finding of violation.
- Represented a video streaming company in a patent infringement suit at a U.S. district court, leading to a successful settlement.
- Advised a global pharmaceutical company headquartered in France through pre-suit due diligence and Hatch-Waxman litigation involving a drug for diabetes and related injection devices.
- Represented a Korean electronics company in a patent infringement suit against a non-practicing entity at a U.S. district court, invalidating a patent at a claim construction hearing and leading to a successful settlement for the client.
Professional Highlights
- Recognized by Best Lawyers: Ones to Watch for Litigation – Intellectual Property (2024–2026)
- Recognized by The American Lawyer’s Litigation Daily’s Litigator of the Week Runners-Up and Shout-Outs (October 18, 2024)
View More
- Publications
- “Relationship Between Prior Art and Time Difference, and Grace Period Regarding Worldwide Simultaneous Release,” Patent (May 2023).
- “Life sciences IP trends from Japan, Korea and China,” Managing Intellectual Property (March 2022).
Education
-
J.D., Georgetown University Law Center, 2015
Ph.D., Biochemistry, University of Tokyo, 2008
M.S., Biochemistry, McGill University, 2003
B.S., Biochemistry, Queens University, 2001
Admissions
-
District of Columbia
New York
U.S. Patent and Trademark Office
Languages
-
Japanese
Korean